頁籤選單縮合
題 名 | Primary Cutaneous Large B-Cell Lymphoma=原發性皮膚大型B細胞淋巴瘤 |
---|---|
作 者 | 陳怡如; 王璽卿; 陳建州; 張淑美; 沈瑞隆; | 書刊名 | 中華皮膚科醫學雜誌 |
卷 期 | 16:4 1998.12[民87.12] |
頁 次 | 頁302-308 |
分類號 | 415.6 |
關鍵詞 | 原發性皮膚大型B細胞淋巴瘤; Cutaneous B-cell lymphoma; Primary; EORTC classification; |
語 文 | 中文(Chinese) |
中文摘要 | 原發性皮膚B 細胞淋巴瘤為一種不侵犯淋巴腺,而原發於皮膚之特殊的惡性淋巴 瘤。它鮮有皮膚以外的病灶。臨床上多以單獨或局部的皮膚病灶為主,其形狀可以是紅色到 紫色的斑塊或腫瘤,表面光滑,且不會有潰爛生成。最常見的位置包括軀幹,頭頸部,及下 肢。 原發性表皮淋巴瘤對放射線治療及化學治療均相當敏感,有絕佳的預後。 根據最新的 EORTC 分類法, 原發性表皮淋巴瘤之五年存活率高達 95%,而其中原發性表皮大型 B 細胞 淋巴瘤的預後稍差且極易復發,五年存活率約在 58%。本文將介紹一發生在局部前臂的原 發性表皮大型 B 細胞淋巴瘤。 |
英文摘要 | Primary cutaneous B-cell lymphomas are a distinct group of extranodal lymphomas that clinically originate from the skin. They rarely have detectable extracutaneous spreading. The clinical manifestations generally include solitary or localized skin lesions, which have smooth, erythematous to violaceous nodules without ulceration, commonly located on the trunk, head and neck region, and lower legs. Primary cutaneous B-cell lymphomas are highly sensitive to radiotherapy and chemotherapy, and have excellent prognosis. According to a new European Organization for Research and Treatment of Cancer (EORTC) classification system, primary cutaneous large B-cell lymphoma has a less favorable outcome (5-year survival, 58%) and a high recurrence rate (50%), in comparison with other cutaneous B- cell lymphomas which have excellent prognosis (5-year survival, >95%). We present a case of primary cutaneous diffuse large B-cell lymphoma on the left forearm. |
本系統中英文摘要資訊取自各篇刊載內容。